NewLink Genetics (NLNK) Reports Q2 Loss of $0.27; Charles J. Link Jr, M.D. to retire as CEO and Chairman
Tweet Send to a Friend
NewLink Genetics (NASDAQ: NLNK) reported Q2 EPS of ($0.27), versus ($0.47) reported last year. NewLink Genetics Corporation (NASDAQ: NLNK) (“NewLink ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
